Breaking News
February 24, 2018 - Will Device Meetings in Europe Suffer Under New Ethics Rule?
February 24, 2018 - Nonstatin drug use increases by 124% in U.S., related expenditures triple
February 24, 2018 - Annual foot screening could help spot heart irregularities in people with diabetes
February 24, 2018 - Researchers developing rapid saliva test to detect Zika virus
February 24, 2018 - For Older Men, Even Light Exercise Helps
February 24, 2018 - Healthy Strategies to Beat Stress
February 24, 2018 - Cancer killing clue could lead to safer and more powerful immunotherapies
February 24, 2018 - Repeated sick days do not affect children’s learning ability, study shows
February 24, 2018 - New two-child policy in China could negatively affect women’s status and gender equality
February 24, 2018 - New research project to determine why mine dust-related lung diseases are on the rise
February 24, 2018 - A Tribute to Dr. Ray Lipicky: The Man Who Transformed Cardiology
February 24, 2018 - ClinicalTrials.gov: Child, Foster
February 24, 2018 - Study shows age doesn’t affect survival in patients with non-Hodgkin lymphoma after HCT
February 24, 2018 - Researchers explore how evolutionary processes guide pathways of cells
February 24, 2018 - Discovery may result in new medication to build stronger muscles in old age
February 24, 2018 - New study identifies possible target for treatment of dangerous allergic reactions
February 24, 2018 - Targeted vaccination can be successful in containing epidemic outbreaks
February 24, 2018 - Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
February 24, 2018 - ‘The Best Deals of Any Payer’: What We Heard This Week
February 24, 2018 - Blood and urine tests developed to indicate autism in children
February 24, 2018 - New low-cost microfluidic device brings single-cell technology to bedside
February 24, 2018 - Covestro and Pittsburgh Penguins announce multi-year unique partnership
February 24, 2018 - Some genes can drive both metastasis and initial stages of tumor growth
February 24, 2018 - Visaris Americas announces installation of fully robotic Vision C digital X-ray suite at OGHS
February 24, 2018 - New discovery could accelerate clinical translation of stem cell-based therapies
February 24, 2018 - Respiratory disease patients with arthritis struggle to use complex inhalers
February 24, 2018 - FDA Alert: Labetalol Hydrochloride Injection by Hospira: Recall
February 24, 2018 - Flu, Tdap Vax Safe for Babies 6 Months Later
February 24, 2018 - Adults with autism show a diminished brain response to hearing their own name
February 24, 2018 - Study provides insight into neurobiology of dying
February 24, 2018 - Study finds tobacco smoke exposure among most adolescents in economically disadvantaged population
February 24, 2018 - U.S. clinical sites evaluating antibody-based therapies to prevent two common bacterial infections
February 24, 2018 - UCLA researchers use fluorescent colored proteins to trace origin of heart cells
February 24, 2018 - UC Riverside researchers discover way to halt cancer metastasis
February 24, 2018 - Home Routines Can Boost a Child’s Readiness for School
February 24, 2018 - FDA Investigating Misuse, Abuse of Gabapentinoids
February 24, 2018 - Scientists find key proteins control risk of osteoarthritis during aging
February 24, 2018 - Izon announce the launch of the qEV2 and qEV10 Exosome Isolation columns
February 24, 2018 - New CSIRO technology can create clean drinking water
February 24, 2018 - Treating sleep-disordered breathing may improve prognosis of heart failure patients
February 24, 2018 - More boys begin school a year late than girls, study finds
February 24, 2018 - Early life exposure to green space could have beneficial effects on cognitive function
February 24, 2018 - Joint Surgery: Aspirin Equals NOAC for Post-Acute VTE Prevention
February 23, 2018 - Scientists identify new marker of arthritis in mice
February 23, 2018 - Beetroot juice supplements may benefit patients with heart failure
February 23, 2018 - New study identifies novel molecular biomarkers of preeclampsia
February 23, 2018 - Researchers discover new link between gut bacteria and obesity
February 23, 2018 - Aimmune Therapeutics’ Pivotal Phase 3 PALISADE Trial of AR101 Meets Primary Endpoint in Patients With Peanut Allergy
February 23, 2018 - Improving Glaucoma Care: Ophthalmology Times
February 23, 2018 - Preventing dementia: The promising, the disappointing and the inconclusive
February 23, 2018 - Duke researchers show how to retrain immune system of peanut-allergy mice
February 23, 2018 - Older males could live longer with light intensity exercise, study suggests
February 23, 2018 - C-sections and gut bacteria linked to childhood obesity risk
February 23, 2018 - Asthmatics have lower degree of DNA methylation in certain immune cells
February 23, 2018 - Uniforms coated with copper nanoparticles could reduce spread of hospital infections
February 23, 2018 - What Not to Do If You Have Asthma and Want to Get Pregnant
February 23, 2018 - Deep brain stimulation may be promising Alzheimer’s treatment
February 23, 2018 - AMSBIO offers new PARPtrap Assay Kit
February 23, 2018 - New study identifies mechanisms to lengthen egg viability in worms
February 23, 2018 - Interventions to improve self-concept could be critical in treating mental health patients
February 23, 2018 - Few minutes of physical activity may lower risk of death in older men, research suggests
February 23, 2018 - Modifications in HIV test enable rapid detection of Zika virus, study states
February 23, 2018 - Could Hackers Target Heart Devices?
February 23, 2018 - Kids’ Mental Health Status Not a Factor in Gun Storage
February 23, 2018 - Revellers ready for festival drug checks, study finds
February 23, 2018 - Stanford researchers explore how enzyme changes and becomes antibiotic-resistant
February 23, 2018 - Scientists decode molecular structure of healthy huntingtin protein
February 23, 2018 - Efficacy of cancer immunotherapy increased by deactivating tumor defence mechanism
February 23, 2018 - Epigenetic changes due to normal aging process linked to cancer risk
February 23, 2018 - Evaluations of Medicaid experiments by states, CMS are weak, GAO says
February 23, 2018 - Biomarkers ID’d for Anesthesia-Related Neural Damage
February 23, 2018 - Study reveals how kidney disease happens
February 23, 2018 - Iron deficiency early in life can have long-lasting consequences for the brain
February 23, 2018 - High protein diet reduces risk of Alzheimer’s disease, research finds
February 23, 2018 - Research extends powerful capabilities of MRI to nanometer scale
February 23, 2018 - Scientists show that cutting-edge technique can efficiently sort nano-sized particles
February 23, 2018 - Dornier’s new laser innovation delivers confidence to glide through deflected scopes
February 23, 2018 - Neurocrine Biosciences Will File New Drug Application for Opicapone for Parkinson’s Disease Based on Existing Pivotal Clinical Trial Data
February 23, 2018 - Bariatric Surgery Enabled Stopping Diabetes Meds
February 23, 2018 - C-sections and gut bacteria increase risk of childhood obesity
Preventing HIV at the initial stages of infection

Preventing HIV at the initial stages of infection

image_pdfDownload PDFimage_print
HIV infecting a human cell. Credit: NIH

In a project funded by the Austrian Science Fund FWF, Doris Wilflingseder investigates the initial stages of HIV infection, a period when the immune system might still stop the virus.

“HIV has been intensively investigated in research labs all over the world for more than 30 years,” says Doris Wilflingseder, and throughout that time it has been resisting effective treatment. “The virus mutates incredibly fast and plays a cat-and-mouse game with our immune system,” adds Wilflingseder, a researcher at the Medical University of Innsbruck. The immunologist heads a research group working on describing the interaction of the virus with the immune system—before the immune deficiency spreads and the body might still defend itself against the virus.

Initial contact as pivotal point

It is known that HIV infiltrates the genetic material of T helper cells, which constitute an essential element of the body’s immune response—and that makes the virus so dangerous. Instead of effectively fighting the intruder, these cells are exploited by the virus and thus support the virus attack until the immune system finally breaks.

“Our approach considers the initial contact between immune cells in the mucosa and the pathogens to be the pivotal point,” explains the scientist. She places her bet on the complement system, the part of the innate immune system which can immediately destroy pathogens. “This part of our immune defence system is not taken into account by most other research teams, although it is a key element in the acute infection phase and can contribute to a successful fight against the virus,” explains Wilflingseder. Basically, the complement system coats the invading HI-virus, thus marking it as such for the immune cells. Dendritic cells are then able to perceive the virus as an intruder and spring into action. These sentinels of the skin and mucosa apprehend anything they perceive as a foreign substance and deliver their prey “free of charge” to T helper and killer T cells.

“Our trials and investigations have illustrated that complement-coated HIV is detected more readily by dendritic cells and, subsequently, more efficiently battled by effector cells than a virus that carries no immunological marker.”

On the basis of these results from cell cultures, a therapeutic vaccine might, in principle, be conceivable—in principle only, because the devil is in the details. In this case, it is the fact that the window of opportunity is only open for two weeks. “After that time, we see the emergence of HIV-specific antibodies that recognise the virus but do not neutralise it in that time span. In this way, the immune response conveyed by the dendritic cells is changed again, since other receptors get stimulated on the cells,” notes Wilflingseder.

“Right now, our research aims at gaining a better understanding of the immune system and these coating processes specifically at the beginning of the infection. We hope this will help us to find ways of strengthening the immune system even during the chronic phase of HIV infection,” says Wilflingseder, putting any premature hopes for treatment into perspective.

The potential of new models

The researcher does see definite success and progress in another field. Doris Wilflingseder started and refined her investigations with the help of cell cultures. “Cell cultures are often very simple. They have none of the more complex structures we find in different types of tissue,” she summarises. For a long time, scientists skirted this disadvantage by using animal testing. “But now we are establishing really good 3-D cell culture models. Lab-grown 3-D structures and organoids increase our chances even further.”

The researcher is convinced that animal testing is not only dubious but also substitutable in many cases. “I collaborate closely with physiologists and bio-informatics experts on developing 3-D cultures.” Wilflingseder contributes her expertise and instinctive understanding of 3-D cultures to this process. “Knowing intuitively when to change the media and when to take samples is important.” Quite frequently, confirms the scholar, the right time does not follow a regular pattern. In order to suss it out one needs experience and creativity. “It’s comparable to cooking. It is striking that people who can cook and bake also have a good instinct for cell cultures.” The new models provide a better way, and, even more importantly, a method involving the human immune system, of investigating cancer and infections in a more relevant system.


Explore further:
Zika-related nerve damage caused by immune response to the virus

More information:
P. Chandorkar et al. Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections, Scientific Reports (2017). DOI: 10.1038/s41598-017-11271-4

Wilfried Posch et al. Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells, PLOS Pathogens (2015). DOI: 10.1371/journal.ppat.1005005

Doris Wilflingseder et al. Immediate T-Helper 17 Polarization Upon Triggering CD11b/c on HIV-Exposed Dendritic Cells, The Journal of Infectious Diseases (2015). DOI: 10.1093/infdis/jiv014

Tagged with:

About author

Related Articles